Pharmacyclics: Motexafin Gadolinium Pharmacyclics, Inc. is developing biopharmaceutical products designed to improve radiation, chemotherapy and photodynamic therapy of certain cancers, atherosclerotic cardiovascular disease and retinal diseases.
A common mistake that people make when trying to design something completely
foolproof is to underestimate the ingenuity of complete fools. - Douglas Adams